Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...
Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...
In the future, around one third of the new products at Boehringer Ingelheim will come from oncology." New high-tech facility Newest technologies and laboratories allow scientists to faster achieve ...
Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable ...
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...
Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...
The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...
"We continue to pursue claims against Boehringer Ingelheim for its wrongdoing in exposing millions of people to a known carcinogen for over a decade. Our fight against Boehringer Ingelheim ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
The first was for Boehringer Ingelheim and GlaxoSmithKline, another Zantac manufacturer, and the second was for GlaxoSmithKline alone. Next up: California's first Zantac trial is set to begin jury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback